Get started
Author

Rachel Roberts

Observed name: Roberts, Rachel
ORCID: 0000-0002-3398-0821
Observed ORCID: 0000-0002-3398-0821
OpenAlex ID: A5023785747
Selection of radionuclide(s) for targeted alpha therapy based on their nuclear decay properties
2024 · Samantha M. Ree, Howard Greenwood, et al. · Nuclear Medicine Communications · 19
Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE Project
2025 · Valentina Di Iorio, Anna Sarnelli, et al. · Pharmaceuticals · 10
PDF
Physical Properties of Highly Active Liquor Containing Molybdate Solids
2016 · Barbara Dunnett, Tracy Ward, et al. · Procedia Chemistry · 8
PDF
A production route for lead-212 for Targeted Alpha Therapy; Using the UK’s nuclear legacy for cancer treatment
2026 · Howard Greenwood, Samantha Ree, et al. · Nuclear Future
Minimising the impact of stable 208Pb on recovery of 212Pb from a generator
2025 · Rachel Roberts, Tim Carthy, et al. · EJNMMI Radiopharmacy and Chemistry
PDF
Reduction of Legionella pneumophila and Pseudomonas aeruginosa bacteria in water using gamma irradiation
2022 · Rachel Roberts, Robin Orr, et al. · Radiation Physics and Chemistry
Works count: 8
Citation count: 37
H-index: 3
I10-index: 2
Year
Topic
Type